The University of Chicago Header Logo

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Elliot Gershon and Sarah K. Keedy.
Connection Strength

2.957
  1. Real-time facial emotion recognition deficits across the psychosis spectrum: A B-SNIP Study. Schizophr Res. 2022 05; 243:489-499.
    View in: PubMed
    Score: 0.202
  2. An opportunity for primary prevention research in psychotic disorders. Schizophr Res. 2022 05; 243:433-439.
    View in: PubMed
    Score: 0.197
  3. Resting state auditory-language cortex connectivity is associated with hallucinations in clinical and biological subtypes of psychotic disorders. Neuroimage Clin. 2020; 27:102358.
    View in: PubMed
    Score: 0.184
  4. Distinguishing patterns of impairment on inhibitory control and general cognitive ability among bipolar with and without psychosis, schizophrenia, and schizoaffective disorder. Schizophr Res. 2020 09; 223:148-157.
    View in: PubMed
    Score: 0.184
  5. No connectivity alterations for striatum, default mode, or salience network in association with self-reported antipsychotic medication dose in a large chronic patient group. Schizophr Res. 2020 09; 223:359-360.
    View in: PubMed
    Score: 0.183
  6. GWAS significance thresholds for deep phenotyping studies can depend upon minor allele frequencies and sample size. Mol Psychiatry. 2021 06; 26(6):2048-2055.
    View in: PubMed
    Score: 0.179
  7. NRXN1 is associated with enlargement of the temporal horns of the lateral ventricles in psychosis. Transl Psychiatry. 2019 09 17; 9(1):230.
    View in: PubMed
    Score: 0.174
  8. Genetic analysis of deep phenotyping projects in common disorders. Schizophr Res. 2018 05; 195:51-57.
    View in: PubMed
    Score: 0.152
  9. Characterizing the Relationship between Personality Dimensions and Psychosis-Specific Clinical Characteristics. medRxiv. 2024 Jun 07.
    View in: PubMed
    Score: 0.060
  10. Categorical and Dimensional Approaches for Psychiatric Classification and Treatment Targeting: Considerations from Psychosis Biotypes. Adv Neurobiol. 2024; 40:685-723.
    View in: PubMed
    Score: 0.058
  11. Clinical characterization and differentiation of B-SNIP psychosis Biotypes: Algorithmic Diagnostics for Efficient Prescription of Treatments (ADEPT)-1. Schizophr Res. 2023 10; 260:143-151.
    View in: PubMed
    Score: 0.057
  12. Peripheral inflammatory subgroup differences in anterior Default Mode network and multiplex functional network topology are associated with cognition in psychosis. Brain Behav Immun. 2023 11; 114:3-15.
    View in: PubMed
    Score: 0.057
  13. Characterization of childhood trauma, hippocampal mediation and Cannabis use in a large dataset of psychosis and non-psychosis individuals. Schizophr Res. 2023 05; 255:102-109.
    View in: PubMed
    Score: 0.055
  14. Peripheral inflammation is associated with impairments of inhibitory behavioral control and visual sensorimotor function in psychotic disorders. Schizophr Res. 2023 05; 255:69-78.
    View in: PubMed
    Score: 0.055
  15. Monoallelic and biallelic mutations in RELN underlie a graded series of neurodevelopmental disorders. Brain. 2022 09 14; 145(9):3274-3287.
    View in: PubMed
    Score: 0.053
  16. A subtype of institutionalized patients with schizophrenia characterized by pronounced subcortical and cognitive deficits. Neuropsychopharmacology. 2022 11; 47(12):2024-2032.
    View in: PubMed
    Score: 0.052
  17. Using psychosis biotypes and the Framingham model for parsing psychosis biology. Schizophr Res. 2022 04; 242:132-134.
    View in: PubMed
    Score: 0.051
  18. Psychosis Biotypes: Replication and Validation from the B-SNIP Consortium. Schizophr Bull. 2022 01 21; 48(1):56-68.
    View in: PubMed
    Score: 0.051
  19. Subtyping Schizophrenia Patients Based on Patterns of Structural Brain Alterations. Schizophr Bull. 2022 01 21; 48(1):241-250.
    View in: PubMed
    Score: 0.051
  20. Impact of polygenic risk for coronary artery disease and cardiovascular medication burden on cognitive impairment in psychotic disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2022 03 08; 113:110464.
    View in: PubMed
    Score: 0.050
  21. Neural Processing of Repeated Emotional Scenes in Schizophrenia, Schizoaffective Disorder, and Bipolar Disorder. Schizophr Bull. 2021 08 21; 47(5):1473-1481.
    View in: PubMed
    Score: 0.050
  22. Auditory Oddball Responses Across the Schizophrenia-Bipolar Spectrum and Their Relationship to Cognitive and Clinical Features. Am J Psychiatry. 2021 10 01; 178(10):952-964.
    View in: PubMed
    Score: 0.050
  23. Genome-wide association study accounting for anticholinergic burden to examine cognitive dysfunction in psychotic disorders. Neuropsychopharmacology. 2021 09; 46(10):1802-1810.
    View in: PubMed
    Score: 0.049
  24. Multivariate relationships between peripheral inflammatory marker subtypes and cognitive and brain structural measures in psychosis. Mol Psychiatry. 2021 07; 26(7):3430-3443.
    View in: PubMed
    Score: 0.047
  25. Biotyping in psychosis: using multiple computational approaches with one data set. Neuropsychopharmacology. 2021 01; 46(1):143-155.
    View in: PubMed
    Score: 0.047
  26. Cognitive Impairment and Diminished Neural Responses Constitute a Biomarker Signature of Negative Symptoms in Psychosis. Schizophr Bull. 2020 Sep 21; 46(5):1269-1281.
    View in: PubMed
    Score: 0.047
  27. Catechol-O-methyltransferase genotype differentially contributes to the flexibility and stability of cognitive sets in patients with psychotic disorders and their first-degree relatives. Schizophr Res. 2020 09; 223:236-241.
    View in: PubMed
    Score: 0.046
  28. Auditory paired-stimuli responses across the psychosis and bipolar spectrum and their relationship to clinical features. Biomark Neuropsychiatry. 2020 Dec; 3.
    View in: PubMed
    Score: 0.045
  29. Testing Psychosis Phenotypes From Bipolar-Schizophrenia Network for Intermediate Phenotypes for Clinical Application: Biotype Characteristics and Targets. Biol Psychiatry Cogn Neurosci Neuroimaging. 2020 08; 5(8):808-818.
    View in: PubMed
    Score: 0.045
  30. NMDA receptor antibody seropositivity in psychosis: A pilot study from the Bipolar-Schizophrenia Network for Intermediate Phenotypes (B-SNIP). Schizophr Res. 2020 04; 218:318-320.
    View in: PubMed
    Score: 0.044
  31. Brain gray matter network organization in psychotic disorders. Neuropsychopharmacology. 2020 03; 45(4):666-674.
    View in: PubMed
    Score: 0.044
  32. Intrinsic neural activity differences in psychosis biotypes: Findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) consortium. Biomark Neuropsychiatry. 2019 Dec; 1.
    View in: PubMed
    Score: 0.044
  33. Electrophysiological correlates of emotional scene processing in bipolar disorder. J Psychiatr Res. 2020 01; 120:83-90.
    View in: PubMed
    Score: 0.044
  34. Auditory steady-state EEG response across the schizo-bipolar spectrum. Schizophr Res. 2019 07; 209:218-226.
    View in: PubMed
    Score: 0.042
  35. Alterations in intrinsic fronto-thalamo-parietal connectivity are associated with cognitive control deficits in psychotic disorders. Hum Brain Mapp. 2019 01; 40(1):163-174.
    View in: PubMed
    Score: 0.040
  36. Peripheral oxytocin and vasopressin modulates regional brain activity differently in men and women with schizophrenia. Schizophr Res. 2018 12; 202:173-179.
    View in: PubMed
    Score: 0.040
  37. Cognitive burden of anticholinergic medications in psychotic disorders. Schizophr Res. 2017 12; 190:129-135.
    View in: PubMed
    Score: 0.037
  38. Sex and diagnosis specific associations between DNA methylation of the oxytocin receptor gene with emotion processing and temporal-limbic and prefrontal brain volumes in psychotic disorders. Biol Psychiatry Cogn Neurosci Neuroimaging. 2016 Mar 01; 1(2):141-151.
    View in: PubMed
    Score: 0.033
  39. Reduced levels of vasopressin and reduced behavioral modulation of oxytocin in psychotic disorders. Schizophr Bull. 2014 Nov; 40(6):1374-84.
    View in: PubMed
    Score: 0.030
  40. Neurophysiological evidence of corollary discharge function during vocalization in psychotic patients and their nonpsychotic first-degree relatives. Schizophr Bull. 2013 Nov; 39(6):1272-80.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.